Pharma giant Eli Lilly said it is negotiating to raise drug prices in Europe, starting in the U.K. with the weight-loss drug Mounjaro, so that it can comply with the Trump administration’s goal of bringing down prices in the U.S.

Eli Lilly said it would raise drug prices in Europe to "make them lower" in U.S., though the actual impact on most patients abroad remains unclear.